Patent details

EP3411392 Title: NON-HUMAN ANIMALS HAVING AN ENGINEERED ANGPTL8 GENE

Basic Information

Publication number:
EP3411392
PCT Application Number:
US2017016487
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177052768
PCT Publication Number:
WO2017136712
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NON-HUMAN ANIMALS HAVING AN ENGINEERED ANGPTL8 GENE
French Title of Invention:
ANIMAUX NON HUMAINS POSSÉDANT UN GÈNE ANGPTL8 MODIFIÉ
German Title of Invention:
NICHTMENSCHLICHE TIERE MIT VERÄNDERTEM ANGPTL8-GEN
SPC Number:

Dates

Filing date:
03/02/2017
Grant date:
29/12/2021
EP Publication Date:
12/12/2018
PCT Publication Date:
10/08/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/12/2021
EP B1 Publication Date:
29/12/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
03/02/2022
Expiration date:
03/02/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/12/2021
 
 

Name:
Regeneron Pharmaceuticals, Inc.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States (US)

Inventor

1

Name:
GUSAROVA, Viktoria
Address:
United States (US)

2

Name:
GROMADA, Jesper
Address:
United States (US)

3

Name:
MURPHY, Andrew J.
Address:
United States (US)

4

Name:
GUO, Dayong
Address:
United States (US)

Priority

Priority Number:
201662291446 P
Priority Date:
04/02/2016
Priority Country:
United States (US)

Classification

IPC classification:
C07K 14/515; A01K 67/027; A61K 49/00; C07K 16/22; A61K 39/00;

Publication

European Patent Bulletin

Issue number:
202152
Publication date:
29/12/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages